Carcinoma, Non-Small-Cell Lung: all 6,645 studies
Page 54 of 67. Open to participants first (1,667), then studies with results posted, then the rest; newest registration first within each.
- Expanded Treatment Protocol With LDK378 in ALK(+) NSCLCNo longer availableNCT01947608
- Time Trends in Waiting Times of NSCLC Patients.WithdrawnNCT01946490
- Treatment of Multifocal Lung AdenocarcinomaTerminatedNCT01946100Not applicable
- Improving Care After ChemotherapyCompletedNCT01944137Not applicable
- Analysis of Treatment Outcome and Toxicity in Non-small Cell Lung Cancer Patients Wither-irradiated to a High Dose for Recurrent DiseaseCompletedNCT01941303
- Safety and Tolerability of Trametinib in Combination With Docetaxel in Japanese Subjects With Non-small Cell Lung CancerWithdrawnNCT01938456Phase 1
- Usefulness of Blood Biomarkers for Overall Survival in NSCLCCompletedNCT01936571
- Efficacy Study of Vx001 Vaccine in NSCLC PatientsCompletedNCT01935154Phase 2
- Bevacizumab Plus Chemotherapy for Advanced Non Small Cell Lung Cancer Patients as 1st Line TreatmentCompletedNCT01934465
- Combined CFRT and SABR in Stage II and III NSCLC With Peripheral Tumors Smaller Than 5 cm.CompletedNCT01933568Phase 1
- Third-line Treatment of Gefitinib in NSCLC PatientsCompletedNCT01933347Phase 2
- The Jules Bordet Institute Molecular Profiling Program Feasibility TrialCompletedNCT01932489Not applicable
- An Open Label Study of BIBW 2992/Afatinib in Advanced Non-Small Cell Lung Cancer Patients Pre-treated With Erlotinib or GefitinibStatus unknownNCT01932229Phase 2
- Expanded Access Study of Afatinib in Treatment-naive or Chemotherapy Pre-treated Patients With Non-small Cell Lung Cancer (NSCLC)Approved for marketingNCT01931306
- Icotinib as Adjuvant Therapy in Treating Non-small-cell Lung Cancer Patients With Positive EGFR MutationStatus unknownNCT01929200Phase 2
- Pemetrexed Disodium and Carboplatin or Cisplatin With or Without Erlotinib Hydrochloride in Treating Patient With Stage IV Non-Small Cell Lung Cancer Resistant to First-Line Therapy With Erlotinib Hydrochloride or GefitinibWithdrawnNCT01928160Phase 2
- Phase II Trial of Regimen for Stage III (N2) NSCLC Using Induction Treatment Followed by ResectionStatus unknownNCT01926483Phase 2
- Lung Cancer Information Study (LCIS-R01)CompletedNCT01924416Not applicable
- Phase II Study of Anlotinib in Patients With Advanced Non-small Cell Lung Cancer（ALTER0302）CompletedNCT01924195Phase 2
- AUY922 in Patient With Stage IV NSCLCCompletedNCT01922583Phase 2
- Stereotactic Precision And Conventional Radiotherapy EvaluationStatus unknownNCT01920789Not applicable
- Trial of RNActive®-Derived Cancer Vaccine and Local Radiation in in Stage IV Non Small Cell Lung Cancer (NSCLC)TerminatedNCT01915524Phase 1
- Evaluation of Cabazitaxel in Patients With Brain Metastasis Secondary to Breast Cancer and NSCLCWithdrawnNCT01913067Phase 2
- Trametinib, Combination Chemotherapy, and Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed by SurgeryTerminatedNCT01912625Phase 1
- INC280 and Erlotinib Hydrochloride in Treating Patients With Non-small Cell Lung CancerCompletedNCT01911507Phase 1
- Phase II Study of Buparlisib + Docetaxel in Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) PatientsTerminatedNCT01911325Phase 1
- Combination Vaccine Immunotherapy (DRibbles) for Patients With Definitively-Treated Stage III Non-small Cell Lung CancerCompletedNCT01909752Phase 2
- Preconditioning Chemotherapy Combination With Cytokine Induced Killer Cell (CIK) ImmunotherapyStatus unknownNCT01902875
- Stereotactic Body Radiation Therapy for Inoperable Locally-advanced Non-small Cell Lung CancerCompletedNCT01899989Phase 1
- A Study of LY2875358 in Participants With Non-Small Cell Lung Cancer With Activating Epidermal Growth Factor Receptor MutationsCompletedNCT01897480Phase 2
- An Observational Study of Avastin (Bevacizumab) in Elderly Patients With Non-Squamous Non-Small Cell Lung Cancer in Clinical PracticeCompletedNCT01893268
- VEGFRs Predict Bevacizumab Benefit in Advanced Non Small Cell Lung CancerStatus unknownNCT01891708
- Explore the Individual Treatment of Docetaxel and Paclitaxel in NSCLC, NPC and BRC by PK-guided Dosing StrategyStatus unknownNCT01891123Not applicable
- TRAcking Non-small Cell Lung Cancer Evolution Through Therapy (Rx)Active, not recruitingNCT01888601
- A Study of Onartuzumab in Combination With Erlotinib in Patients With MET-Positive Stage IIIB or IV Non-Small Cell Lung Cancer Carrying an Activating Epidermal Growth Factor Receptor (EGFR) MutationCompletedNCT01887886Phase 3
- Phase Ⅲ Trial of WBRT Versus Erlotinib Concurrent Whole-brain Radiation Therapy as first-line Treatment for Patients With Multiple Brain Metastases From Non-small-cell Lung Cancer(ENTER): a Multicentre, Open-label, Randomised StudyCompletedNCT01887795Phase 3
- Azacitidine and Entinostat in Treating Patients With Newly Diagnosed Stage IA-IIIA Non-Small Lung Cancer Undergoing SurgeryTerminatedNCT01886573Phase 1
- Characterization of Peripheral Muscle Function in Patients With Non-small-cell Lung CancerStatus unknownNCT01885754
- Improving Resection Rates Among African Americans With NSCLCCompletedNCT01885455Not applicable
- AZD8186 First Time In Patient Ascending Dose StudyCompletedNCT01884285Phase 1
- Monosialoganglioside(GM1) Preventing Neurotoxicity Induced by Cisplatin Contained Chemotherapy in NSCLC PatientsStatus unknownNCT01882621Phase 3
- Study Of Use Of Pemetrexed In Patients With Non-Small Lung Cancer Metastatic In Andalusian Public Health SystemStatus unknownNCT01877902
- A Study of TS-1 Plus Cisplatin in Patients With Advanced Non-small-cell Lung CancerCompletedNCT01874678Not applicable
- CIK Cell Transfusion Plus Gefitinib As Second Or Third-Line Treatment for Advanced Adenocarcinoma Non-Small Cell Lung CancerTerminatedNCT01871480Phase 2
- Combination of Metformin With Gefitinib to Treat NSCLCCompletedNCT01864681Phase 2
- A Phase I Study of iPS Cell Generation From Patients With COPDCompletedNCT01860898Not applicable
- A Study of PC Sequential Pemetrexed Single Drug Maintenance Treatment for NSCLC and Related Predictive BiomarkersStatus unknownNCT01860508Not applicable
- A Phase I/IB Trial of MEK162 in Combination With Erlotinib in NSCLC Harboring KRAS or EGFR MutationCompletedNCT01859026Phase 1
- Photodynamic Therapy During Surgery in Treating Patients With Non-small Cell Lung Cancer That Can Be Removed by SurgeryCompletedNCT01854684Phase 1
- Cabazitaxel in Relapsed and Metastatic NSCLCCompletedNCT01852578Phase 2
- Maintenance After Induction Chemotherapy in Elderly Patients With Advanced Non-small Cell Lung CancerCompletedNCT01850303Phase 3
- Study of Patient Preference for Oral or Intravenous Vinorelbine in the Treatment of Advanced NSCLCCompletedNCT01848613Phase 4
- An Exploratory Study of OCZ103-OS in Combination With Standard of Care in Stage IV Non-Small Cell Lung Cancer (NSCLC) PatientsCompletedNCT01844791Phase 2
- Neoadjuvant Therapy of Icotinib in Epidermal Growth Factor Receptor Mutated NSCLC PatientsStatus unknownNCT01843647Phase 2
- Study to Evaluate NA-NOSE for Monitoring and Detecting Recurrence in Early Stage Lung CancerCompletedNCT01840150Not applicable
- Erlotinib Hydrochloride and Quinacrine Dihydrochloride in Stage IIIB-IV Non-Small Cell Lung CancerCompletedNCT01839955Phase 1
- Genetics of EGFR (Epidermal Growth Factor Receptor) Mutation StudyStatus unknownNCT01838577
- Analysis of the Incidence of Expression of Tumor Antigens in Pathologically Proven Stage I, II and III Non-Small Cell Lung Cancer(NSCLC) in Asiatic PatientsCompletedNCT01837511
- Phase I Study of Tetrathiomolybdate in Combination With Carboplatin/Pemetrexed in Metastatic Non-small Cell Lung CancerCompletedNCT01837329Phase 1
- Empyema Following Pneumonectomy for Non Small Cell Lung Cancer (NSCLC)CompletedNCT01837186
- Isotoxic Intensity Modulated Radiotherapy (IMRT) in Stage III Non Small Cell Lung Cancer (NSCLC) - A Feasibility StudyCompletedNCT01836692Not applicable
- Chidamide in Combination With Carboplatin and Paclitaxel in Advanced Non-small Cell Lung CancerCompletedNCT01836679Phase 2
- Alimta® Versus Its Combination With Carboplatin in Advanced Non-small-cell Lung Cancer in Patients Performance Status 2CompletedNCT01836575Phase 3
- Preoperative Gefitinib for EGFR Mutant II-IIIa NSCLC (ECTOP-1001)CompletedNCT01833572Phase 2
- Circulating Tumor Cells in Non-Small Cell Lung CarcinomaCompletedNCT01830426
- Vandetanib in Advanced NSCLC With RET RearrangementCompletedNCT01823068Phase 2
- Risk Adapted SABR(SABR) in Stage I NSCLC And Lung MetastasesStatus unknownNCT01823003Phase 2
- Safety and Efficacy of Buparlisib (BKM120) in Patients With Untreated Squamous Non-small Cell Lung CancerTerminatedNCT01820325Phase 1
- Phase 1 Study of Fusilev® to Prevent or Reduce Mucositis in Patients With Non-Small Cell Lung Cancer Receiving Folotyn®WithdrawnNCT01820091Phase 1
- Adjuvant Chemotherapy in Patients With Intermediate or High Risk Stage I or Stage IIA Non-squamous Non-Small Cell Lung Cancer: AIM-HIGH (Adjuvant Intervention in Molecular High Risk Patients)Active, not recruitingNCT01817192Not applicable
- Benefits Study of Respiratory-gated PET Acquisition in Lung DiseaseCompletedNCT01812031Not applicable
- ABX Combined With Cisplatin Compared With Gemcitabine Combined With Cisplatin in NSCLCCompletedNCT01810367Phase 2
- Registry Study of Thoracic Reirradiation for Non-Small Cell Lung Cancer (NSCLC) Utilizing Proton Beam Therapy or Intensity Modulated Radiation TherapyCompletedNCT01808677
- Docetaxel With or Without Low-dose, Short Course Sunitinib in Refractory Solid TumorsStatus unknownNCT01803503Phase 2
- Effect of Astragalus-based Formula: Qingshu-Yiqi-Tang on Modulating Immune Alterations in Lung Cancer PatientsStatus unknownNCT01802021Phase 2/3
- Role of Rapid On-site Evaluation for Mutational Analysis of EBUS-TBNA SpecimensCompletedNCT01799382Not applicable
- Combination of gp96-Ig Vaccine, Theophylline and Oxygen for the Treatment of Patients With Advanced, Relapsed or Metastatic Non-Small Cell Lung CancerWithdrawnNCT01799161Phase 1
- The Study of Gemcitabine in the Maintenance Treatment of Advanced Non-small Cell Lung CancerCompletedNCT01797913Phase 2
- The Value of Radiotherapy in the Oligometastatic Non-squamous Non-small Cell Lung Cancer With Clinical Benefits From Erlotinib as Second-line TreatmentStatus unknownNCT01796288Phase 2
- LungTech: Stereotactic Body Radiotherapy (SBRT) of Inoperable Centrally Located NSCLCStatus unknownNCT01795521Phase 2
- Retrospective Study in a NSCLC M+ pCompletedNCT01795352
- A Phase 2 Study to Determine the Safety and Efficacy of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) as Second-line Therapy to Patients With Non-Small Cell Lung CancerCompletedNCT01792479Phase 2
- An Observational Study of Tarceva (Erlotinib) in First Line in Patients With Advanced EGFR Mutation-Positive Non-Small Cell Lung Cancer (GERTAC)CompletedNCT01790217
- A Phase I/IIa Study of UV1 Vaccination in Patients With Non Small Cell Lung Cancer.CompletedNCT01789099Phase 1/2
- Parp Inhibitor in Advanced Non-Small Cell Lung Cancer (PIN)Status unknownNCT01788332Phase 2
- Clinical Trial: Effectiveness and Efficiency of Physical Exercise in Cancer PatientsStatus unknownNCT01786122Not applicable
- Pemetrexed Disodium and Hsp90 Inhibitor AUY922 in Treating Patients With Previously Treated Stage IV Non-Small Cell Lung CancerCompletedNCT01784640Phase 1
- Customized Neoadjuvant Versus Standard Chemotherapy in NSCL Patients With Resectable Stage IIIA (N2)DiseaseStatus unknownNCT01784549Phase 2
- Gefitinib Versus Pemetrexed for Previously Treated NSCLC PatientsCompletedNCT01783834Phase 2
- Study of Selumetinib in Patients With Previously Treated or Untreated Advanced/Metastatic NSCLCCompletedNCT01783197Phase 1
- Stereotactic Body Radiation Therapy After Surgery in Treating Patients With Stage III-IV Non-small Cell Lung CancerCompletedNCT01781741Early Phase 1
- Evaluation of EGFR TKI Resistance Mechanism Using Plasma DNA AnalysisStatus unknownNCT01776684Not applicable
- Immunotherapy Study in Progressive or Relapsed Non-Small Cell Lung CancerTerminatedNCT01774578Phase 2/3
- Phase Ib Study of LDK378 and AUY922 in ALK-rearranged Non-small Cell Lung CancerCompletedNCT01772797Phase 1
- Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of Simotinib Hydrochloride in Patients With Advanced NSCLCStatus unknownNCT01772732Phase 1
- NSCLC Burden of Illness StudyCompletedNCT01772225
- Neoadjuvant Concurrent Chemoradiation With Weekly Docetaxel/Cisplatin for Resectable IIIA-N2 NSCLCStatus unknownNCT01771289Phase 2
- A Phase II Trial of Genexol-PM and Gemcitabine in Patients With Advanced Non-small-cell Lung CancerCompletedNCT01770795Phase 2
- A Phase I/II Study of Hypofractionated Proton Therapy for Stage II-III Non-Small Cell Lung CancerActive, not recruitingNCT01770418Phase 1/2
- Comparison of Sequencing and PNA Clamping of EGFR Gene in Patients With Non-Small Cell Type Lung CancerStatus unknownNCT01767974